1. Home
  2. BLTE vs OII Comparison

BLTE vs OII Comparison

Compare BLTE & OII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLTE
  • OII
  • Stock Information
  • Founded
  • BLTE 2018
  • OII 1964
  • Country
  • BLTE United States
  • OII United States
  • Employees
  • BLTE N/A
  • OII N/A
  • Industry
  • BLTE Biotechnology: Pharmaceutical Preparations
  • OII Oilfield Services/Equipment
  • Sector
  • BLTE Health Care
  • OII Energy
  • Exchange
  • BLTE Nasdaq
  • OII Nasdaq
  • Market Cap
  • BLTE 1.9B
  • OII 2.2B
  • IPO Year
  • BLTE 2022
  • OII N/A
  • Fundamental
  • Price
  • BLTE $61.10
  • OII $19.05
  • Analyst Decision
  • BLTE Strong Buy
  • OII Hold
  • Analyst Count
  • BLTE 4
  • OII 5
  • Target Price
  • BLTE $96.67
  • OII $28.00
  • AVG Volume (30 Days)
  • BLTE 25.3K
  • OII 959.6K
  • Earning Date
  • BLTE 05-14-2025
  • OII 04-23-2025
  • Dividend Yield
  • BLTE N/A
  • OII N/A
  • EPS Growth
  • BLTE N/A
  • OII 67.93
  • EPS
  • BLTE N/A
  • OII 1.78
  • Revenue
  • BLTE N/A
  • OII $2,736,592,000.00
  • Revenue This Year
  • BLTE N/A
  • OII $4.95
  • Revenue Next Year
  • BLTE N/A
  • OII $3.37
  • P/E Ratio
  • BLTE N/A
  • OII $10.71
  • Revenue Growth
  • BLTE N/A
  • OII 10.04
  • 52 Week Low
  • BLTE $40.00
  • OII $15.46
  • 52 Week High
  • BLTE $86.53
  • OII $30.98
  • Technical
  • Relative Strength Index (RSI)
  • BLTE 51.45
  • OII 52.96
  • Support Level
  • BLTE $59.04
  • OII $18.27
  • Resistance Level
  • BLTE $62.55
  • OII $18.89
  • Average True Range (ATR)
  • BLTE 2.51
  • OII 0.76
  • MACD
  • BLTE 0.32
  • OII 0.27
  • Stochastic Oscillator
  • BLTE 74.06
  • OII 82.84

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About OII Oceaneering International Inc.

Oceaneering International Inc is a global provider of engineered services and products robotic solutions to the offshore energy, defense, aerospace, manufacturing and entertainment industries. Most of Oceaneering's products are produced for the offshore oil and gas market. It had a 2020 segment realignment to promote synergies and cost efficiency. The five segments are subsea robotics; manufactured products; offshore projects group; integrity management and digital solutions; and aerospace and defense technologies. Within the segments are two businesses - services and products provided primarily to the oil and gas industry. The firm is also involved in the offshore renewables and mobility solutions industries.

Share on Social Networks: